LUPIN PHARMS FDA Approval ANDA 065355

ANDA 065355

LUPIN PHARMS

FDA Drug Application

Application #065355

Application Sponsors

ANDA 065355LUPIN PHARMS

Marketing Status

Prescription001

Application Products

001FOR SUSPENSION;ORAL200MG/5ML0SUPRAXCEFIXIME

FDA Submissions

ORIG1AP2007-04-10
LABELING; LabelingSUPPL18AP2013-03-29STANDARD
LABELING; LabelingSUPPL20AP2016-07-11STANDARD

Submissions Property Types

SUPPL18Null15
SUPPL20Null7

TE Codes

001PrescriptionAB

CDER Filings

LUPIN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65355
            [companyName] => LUPIN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"SUPRAX","activeIngredients":"CEFIXIME","strength":"200MG\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SUPRAX","submission":"CEFIXIME","actionType":"200MG\/5ML","submissionClassification":"FOR SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.